Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Efficacy of CDK4/6 inhibitors combined with endocrine therapy in HR+/HER2− breast cancer: an umbrella reviewPu, Dongqing ; Xu, Debo ; Wu, Yue ; Chen, Hanhan ; Shi, Guangxi ; Feng, Dandan ; Zhang, Mengdi ; Liu, Zhiyong ; Li, JingweiJournal of cancer research and clinical oncology, 2025-01, Vol.150 (1), p.16-16, Article 16 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
2 |
Material Type: Artigo
|
Derivation and validation of a nomogram based on clinical characteristics to diagnose endometriosis associated ovarian cancer preoperativelyXu, Ting ; Nie, Xianglin ; Zhang, Lin ; Meng, Huangyang ; Jiang, Yi ; Wan, Yicong ; Cheng, WenjunJournal of cancer research and clinical oncology, 2025-01, Vol.150 (1), p.19-19, Article 19 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
3 |
Material Type: Artigo
|
Gastroenteropancreatic neuroendocrine carcinoma in children and adolescents: a population-based studyLin, Weilong ; Zhu, Zhitao ; Shang, YupingJournal of cancer research and clinical oncology, 2025-01, Vol.150 (1), p.4-4, Article 4 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
4 |
Material Type: Artigo
|
Hypofractionated versus standard chemoradiotherapy in the definitive treatment of uterine cervix cancer: interim results of a randomized controlled clinical trialMaddah Safaei, Afsane ; Esmati, Ebrahim ; Gomar, Marzieh ; Akhavan, Setareh ; Sheikh Hasani, Shahrzad ; Malekzadeh Moghani, Mona ; Zamani, Narges ; Moshtaghi, Maryam ; Malek, Mahrooz ; Jafari, Fatemeh ; Sharifian, Azadeh ; Kolahdouzan, KasraJournal of cancer research and clinical oncology, 2025-01, Vol.150 (1), p.20-20, Article 20 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
5 |
Material Type: Artigo
|
Efficacy and safety of first-line therapy in patients with HER2-positive advanced breast cancer: a network meta-analysis of randomized controlled trialsWang, Junxiao ; Yu, Yushuai ; Lin, Qisheng ; Zhang, Jie ; Song, ChuanguiJournal of cancer research and clinical oncology, 2025-01, Vol.150 (1), p.21-21, Article 21 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
6 |
Material Type: Artigo
|
Assessing the determinants of influenza and COVID-19 vaccine co-administration decisions in the elderlyKwon, Seunghyun Lewis ; Kim, So-Yeon ; Song, Minju ; Lee, Hyung-Min ; Ban, Seon-Hwa ; Lee, Mi-Soon ; Jeong, HyesunHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2346966-2346966 [Periódico revisado por pares]United States: Taylor & FrancisTexto completo disponível |
|
7 |
Material Type: Artigo
|
Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine: CommentDaungsupawong, Hinpetch ; Wiwanitkit, VirojHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2306032-2306032 [Periódico revisado por pares]United States: Taylor & FrancisTexto completo disponível |
|
8 |
Material Type: Artigo
|
Public health impact of herpes zoster vaccination on older adults in Singapore: a modeling studyOh, Helen ; Tan, Carol ; Williams, Charles ; Giannelos, Nikolaos ; Ng, CherylHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2348839-2348839 [Periódico revisado por pares]United States: Taylor & FrancisTexto completo disponível |
|
9 |
Material Type: Artigo
|
Factors associated with HPV vaccine hesitancy among college students: A cross-sectional survey based on 3Cs and structural equation model in ChinaChen, Cheng ; Chen, Ting ; Huang, Mingzhao ; Huang, Yan ; Zhang, Luying ; Li, PindongHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2309731-2309731 [Periódico revisado por pares]United States: Taylor & Francis GroupTexto completo disponível |
|
10 |
Material Type: Artigo
|
How did the introduction of the measles-containing vaccine second dose (MCV2) affect measles vaccine uptake? - evidence from NigeriaSato, RyokoHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2355036-2355036 [Periódico revisado por pares]United States: Taylor & FrancisTexto completo disponível |